Marco Siccardi

@siccardi_marco

Love science and in particular pharmacology and nanomedicine. Humble food practitioner and lifelong beer scholar.

Vrijeme pridruživanja: studeni 2014.

Tweetovi

Blokirali ste korisnika/cu @siccardi_marco

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @siccardi_marco

  1. proslijedio/la je Tweet

    Our last hour of general assembly is taking place. Thank you for all the discussion and special thanks to our advisery board.

    , , i još njih 5
    Poništi
  2. proslijedio/la je Tweet
    18. stu 2019.
    Poništi
  3. 1. stu 2019.

    We are hiring! Looking for a Research Assistant on PK modelling and ? Apply here

    Poništi
  4. proslijedio/la je Tweet

    Staff awards nominations are in! Good luck to everyone (especially our ITM staff of course🤣)

    Poništi
  5. proslijedio/la je Tweet
    4. lis 2019.

    Today 04/10/19 we launched ⁦⁩ PhD prog with 11 students supported >22 supervisors in tech4 healthy ageing led by ⁦⁩ ⁦⁩ ⁦⁩⁦⁩ ⁦⁩ ⁦⁩ ⁦

    Poništi
  6. proslijedio/la je Tweet
    5. lis 2019.

    Excellent launch of our doctoral training network in Tech4healthyageing

    Poništi
  7. proslijedio/la je Tweet
    27. ruj 2019.

    Hiring! KTP Associate: Looking for an exciting opportunity that bridges between academic and commercial research, and between Chemistry and Biological disciplines? Well we have an 18 month post that could be perfect.

    Prikaži ovu nit
    Poništi
  8. 22. ruj 2019.

    Fantastic collaboration with . Great example of how pharmacokinetic modelling can help the design of novel strategies for drug delivery.

    Poništi
  9. proslijedio/la je Tweet

    reported succesfully about the first project period this week in at the . Thanks to the team for the work and thanks to our PO and PTA

    , , i još njih 4
    Poništi
  10. proslijedio/la je Tweet
    12. ruj 2019.

    Recent Publication: Considerations and challenges in developing novel long-acting antiretrovirals modalities for treatment and prevention of HIV-1 infection: a regulatory perspective.

    Poništi
  11. proslijedio/la je Tweet
    12. ruj 2019.

    Using thalidomide & efavirenz as case studies, et al describe the utility of PBPK models to assess prenatal drug exposure in this paper.

    Poništi
  12. 10. ruj 2019.

    On my way back from the meeting. Excellent presentations, great networking and engaging debates!!

    Poništi
  13. proslijedio/la je Tweet
    23. kol 2019.

    We (me and ) have a PDRA role available that will be working on the project with Unilever to increase the use of recycled plastics in consumer bottles. Can you please promote this to any potentially interested researchers, thanks!

    Poništi
  14. proslijedio/la je Tweet
    20. kol 2019.
    Poništi
  15. proslijedio/la je Tweet
    18. kol 2019.

    Our new paper on detection of +TCells in the Human vs Mouse in has been published!

    Poništi
  16. proslijedio/la je Tweet

    “...parents who have decided not to ...are being influenced by , social media and anti-vaccination campaigns.” Professor Calum Semple interviewed on today about the UK losing its free status (>2h:21m)

    Poništi
  17. 20. kol 2019.
    Poništi
  18. proslijedio/la je Tweet
    Poništi
  19. proslijedio/la je Tweet
    9. kol 2019.

    Recent Publication: Long-acting or extended-release antiretroviral products for HIV treatment and prevention in infants, children, adolescents, and pregnant and breastfeeding women: knowledge gaps and research priorities.

    Poništi
  20. proslijedio/la je Tweet
    26. srp 2019.

    Delighted to be hosting the 5th Early Career Researchers’ Annual Meeting of the British Society of Nanomedicine!

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·